{"gene":"TBCD","run_date":"2026-06-10T10:51:54","timeline":{"discoveries":[{"year":2010,"finding":"TBCD functions in vitro in CCT-driven tubulin folding reactions and in tubulin disruption reactions; it also acts as a GTPase-activating protein (GAP) together with TBCC to stimulate GTP hydrolysis by β-tubulin in the heterodimer at concentrations below those required for polymerization. Bovine TBCD forms a stoichiometric co-complex with β-tubulin when expressed in HeLa cells, whereas human TBCD does not. siRNA-mediated suppression of ARL2 enables human TBCD to disrupt microtubule integrity in vivo, demonstrating that ARL2 negatively regulates TBCD's microtubule-destabilizing activity.","method":"In vitro CCT folding assays, tubulin disruption assays, GTPase-activating protein (GAP) assays, recombinant protein expression in HeLa cells with Co-IP/co-complex analysis, siRNA knockdown of ARL2","journal":"Cytoskeleton (Hoboken, N.J.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal in vitro biochemical assays (folding, disruption, GAP activity) combined with cell-based genetic suppression (siRNA of ARL2), all in a single focused mechanistic study","pmids":["20740604"],"is_preprint":false},{"year":2010,"finding":"TBCD localizes to the centrosome and midbody in a cell-cycle-dependent manner: at the daughter centriole in G1, on procentrioles in S phase, and at the midbody during cytokinesis. Overexpression of TBCD causes microtubule release from the centrosome and G1 arrest; depletion causes mitotic aberrations and incomplete microtubule retraction at the midbody during cytokinesis. In differentiating ciliated cells, TBCD organizes into centriolar rosettes, supporting a role in both canonical and de novo centriolar assembly.","method":"Immunofluorescence localization, cell-cycle staging, TBCD overexpression and siRNA depletion with phenotypic readouts (mitotic aberrations, G1 arrest, cytokinesis defects), analysis in differentiating ciliated cells","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization experiments with defined functional consequences from both loss-of-function (depletion) and gain-of-function (overexpression), multiple orthogonal readouts in a single study","pmids":["20107510"],"is_preprint":false},{"year":2017,"finding":"TBCD, ARL2, and β-tubulin form a stable ~200 kDa trimeric complex (TBCD·ARL2·β-tubulin) in mouse tissues and multiple cell lines. The trimer was purified from human embryonic kidney cells. ARL2 point mutants that disrupt binding to TBCD impair proper maintenance of microtubule densities in cells, establishing that the ARL2–TBCD interaction within the trimer is required for normal microtubule network maintenance.","method":"Non-denaturing gel electrophoresis with immunoblotting, affinity purification from HEK cells, ARL2 point mutant analysis, microtubule density quantification","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — complex purified and characterized by multiple methods (native gels, immunoblot, purification), mutational validation of functional significance, replicated across tissues and cell lines","pmids":["28126905"],"is_preprint":false},{"year":2017,"finding":"Within the TBCD·ARL2·β-tubulin trimer, it is ARL2 (not β-tubulin) that exchanges GTP; ARL2 nucleotide-binding affinity for GTP is increased within the trimer compared to ARL2 monomer. Guanine nucleotide binding to ARL2 drives conformational changes in β-tubulin as detected by altered solvent accessibility. β-tubulin in the trimer also co-purifies with guanine nucleotide. The complex represents a functional intermediate in the β-tubulin folding pathway regulated by ARL2 nucleotide cycling.","method":"Hydrogen/deuterium exchange mass spectrometry (HDX-MS), nucleotide-binding assays, comparison of ARL2 monomer vs. trimer dynamics","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — structural dynamics (HDX-MS) combined with direct nucleotide-binding assays and mutagenesis-informed modeling, single lab but multiple orthogonal biochemical methods","pmids":["28970104"],"is_preprint":false},{"year":2016,"finding":"Pathogenic missense mutations in TBCD reduce protein stability (variably reduced TBCD levels in patient fibroblasts) and impair β-tubulin binding. Loss of TBCD function decreases soluble α/β-tubulin levels and accelerates microtubule polymerization, resulting in a more rapidly growing, stable microtubule population. Patient fibroblasts display aberrant mitotic spindles with disorganized tangle-shaped microtubules and reduced aster formation.","method":"Biochemical analysis of patient-derived fibroblasts (protein level quantification, β-tubulin binding assays), microtubule polymerization assays, immunofluorescence of mitotic spindles, molecular dynamics simulations","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (binding assays, polymerization assays, spindle imaging) in patient-derived cells, independently replicated across two simultaneous publications","pmids":["27666370"],"is_preprint":false},{"year":2016,"finding":"Most pathogenic TBCD missense mutations impair binding of TBCD to ARL2, TBCE, and β-tubulin in cell-based interaction experiments. In vivo experiments using Drosophila melanogaster olfactory projection neurons showed TBCD mutations cause loss-of-function phenotypes.","method":"In vitro cell-based binding experiments (co-immunoprecipitation/pulldown of mutant TBCD with ARL2, TBCE, β-tubulin), Drosophila in vivo genetics","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-based binding and in vivo model organism experiments with functional readout, single lab","pmids":["27666374"],"is_preprint":false},{"year":2016,"finding":"In utero shRNA-mediated suppression of tbcd in the developing mouse brain impairs cortical cell proliferation and radial migration, establishing TBCD as required for normal cerebral cortex development. Mutant TBCD proteins (A475T and A586V) show partially compromised ability to participate in the heterodimer assembly pathway, with reduced intracellular TBCD abundance (~10% and ~40% of control, respectively).","method":"In utero shRNA knockdown in mouse brain with histological analysis of cell proliferation and radial migration; functional assembly assays with mutant proteins; protein quantification in patient fibroblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo genetic loss-of-function (in utero shRNA) with defined cellular phenotype plus biochemical functional assay of mutant proteins, multiple orthogonal methods","pmids":["28158450"],"is_preprint":false},{"year":2016,"finding":"Reduced TBCD expression in patient fibroblasts is associated with accelerated microtubule re-polymerization. Morpholino-mediated TBCD knockdown in zebrafish recapitulates key disease pathological features, and TBCD overexpression in zebrafish confirms an obligate dependency on proper TBCD dosage for normal development.","method":"Microtubule re-polymerization assays in patient-derived fibroblasts, morpholino knockdown and overexpression in zebrafish with phenotypic analysis","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two model systems (patient fibroblasts and zebrafish) with functional readouts, single lab","pmids":["27807845"],"is_preprint":false},{"year":2023,"finding":"CRISPR/Cas9 correction of a pathogenic TBCD missense substitution in patient-derived iPSCs restored proper TBCD protein levels, rescued mitotic spindle organization, and reduced cellular death, confirming that loss of TBCD function directly causes mitotic spindle disorganization and increased cell death.","method":"CRISPR/Cas9 isogenic iPSC correction, protein level quantification, mitotic spindle immunofluorescence, cell death assays","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic correction with multiple functional readouts (protein level, spindle organization, cell death), single lab","pmids":["37175696"],"is_preprint":false},{"year":2025,"finding":"Bovine TBCD (bTBCD) specifically competes with α-tubulin to bind β-tubulin; when bTBCD binds β-tubulin, it fails to form a functional TBCD/β-tubulin/ARL2 complex, resulting in α-tubulin degradation and microtubule depolymerization. This depolymerization combined with an unbalanced β/α-tubulin ratio leads to cell cycle arrest and cell death via activation of non-canonical NF-κB and TNF-α signaling pathways with increased ROS production.","method":"Protein binding competition assays, microtubule depolymerization assays, RNA-seq pathway analysis, ROS measurement, in vivo tumor xenograft experiments","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple biochemical and cell-based assays in a single lab study; bovine TBCD specifically, not human TBCD","pmids":["41232862"],"is_preprint":false},{"year":2017,"finding":"TBCD and TBCE proteins are expressed in human sperm (localized mainly to the middle piece and tail) and in human oocytes (cytosolic localization), as determined by RT-PCR, western blot, and immunofluorescence. TBCD mRNA is present in oocytes but not sperm.","method":"RT-PCR, western blot, immunofluorescence on human sperm and oocytes","journal":"Zygote (Cambridge, England)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — localization established by immunofluorescence in gametes with no functional consequence tested; single lab, single study","pmids":["28583220"],"is_preprint":false}],"current_model":"TBCD is a tubulin-specific chaperone that functions downstream of the CCT chaperonin to facilitate de novo αβ-tubulin heterodimer assembly; it forms a stable ~200 kDa trimer with ARL2 and β-tubulin (the functional form in cells), acts together with TBCC as a GTPase-activating protein for β-tubulin, and can also drive heterodimer disassembly—an activity negatively regulated by ARL2—while at the centrosome/midbody it participates in centriologenesis, spindle organization, and cytokinetic abscission, with nucleotide cycling on ARL2 within the trimer driving conformational changes in β-tubulin to regulate the β-tubulin folding pathway."},"narrative":{"mechanistic_narrative":"TBCD is a tubulin-specific cofactor that operates downstream of the CCT chaperonin in the de novo assembly of αβ-tubulin heterodimers, where it functions in CCT-driven folding reactions and, together with TBCC, acts as a GTPase-activating protein stimulating GTP hydrolysis by β-tubulin within the heterodimer [PMID:20740604]. In cells its functional form is a stable ~200 kDa trimer of TBCD, ARL2, and β-tubulin, and disruption of the ARL2–TBCD interaction impairs maintenance of normal microtubule densities [PMID:28126905]; within this trimer it is ARL2, not β-tubulin, that exchanges guanine nucleotide, and ARL2 nucleotide cycling drives conformational changes in β-tubulin, making the complex a regulated intermediate in the β-tubulin folding pathway [PMID:28970104]. TBCD additionally drives tubulin heterodimer disassembly, an activity that ARL2 negatively regulates, since suppression of ARL2 allows TBCD to disrupt microtubule integrity in vivo [PMID:20740604]. TBCD localizes to the centrosome and midbody in a cell-cycle-dependent manner and contributes to centriologenesis, spindle organization, and cytokinesis, with overexpression causing microtubule release and G1 arrest and depletion causing mitotic and cytokinetic defects [PMID:20107510]. Pathogenic missense mutations in TBCD reduce protein stability and impair binding to β-tubulin, ARL2, and TBCE, lowering soluble tubulin levels, accelerating microtubule polymerization, and producing disorganized mitotic spindles [PMID:27666370, PMID:27666374]; loss of TBCD function impairs cortical neuron proliferation and radial migration and causes a neurodevelopmental disorder, with CRISPR correction of a patient mutation rescuing spindle organization and cell death [PMID:28158450, PMID:37175696].","teleology":[{"year":2010,"claim":"Established the dual biochemical activities of TBCD in the tubulin pathway, showing it both participates in folding and acts as a β-tubulin GAP with TBCC, while identifying ARL2 as a negative regulator of its destabilizing activity.","evidence":"In vitro CCT folding, tubulin disruption, and GAP assays plus recombinant expression and ARL2 siRNA in HeLa cells","pmids":["20740604"],"confidence":"High","gaps":["Did not resolve the structural basis of ARL2 regulation","Difference between bovine and human TBCD co-complex behavior unexplained"]},{"year":2010,"claim":"Defined TBCD's spatial and cell-cycle-dependent role at centrosomes and midbody, linking its biochemical activity to centriologenesis, spindle organization, and cytokinesis.","evidence":"Immunofluorescence localization with overexpression and siRNA phenotyping in cultured and differentiating ciliated cells","pmids":["20107510"],"confidence":"High","gaps":["Mechanism connecting tubulin chaperone activity to centriole assembly not defined","Direct centriolar binding partners not identified"]},{"year":2016,"claim":"Connected TBCD to human disease by showing pathogenic mutations destabilize the protein, impair tubulin/cofactor binding, perturb microtubule dynamics, and cause neurodevelopmental phenotypes in patient cells and model organisms.","evidence":"Patient fibroblast biochemistry, microtubule polymerization assays, spindle imaging, in utero mouse shRNA, zebrafish morpholino, and Drosophila genetics","pmids":["27666370","27666374","28158450","27807845"],"confidence":"High","gaps":["Genotype-phenotype correlation across mutations incompletely resolved","Brain-specific dependency mechanism not fully defined"]},{"year":2017,"claim":"Resolved the functional form of TBCD in cells as a stable trimer with ARL2 and β-tubulin and showed the ARL2-TBCD interface is required for microtubule network maintenance.","evidence":"Native gels, affinity purification from HEK cells, and ARL2 point mutant analysis with microtubule density quantification across tissues and cell lines","pmids":["28126905"],"confidence":"High","gaps":["Atomic-resolution structure of the trimer not determined","Stoichiometry of higher-order assemblies unknown"]},{"year":2017,"claim":"Established the nucleotide logic of the trimer, demonstrating that ARL2 (not β-tubulin) cycles GTP and that ARL2 nucleotide binding allosterically reshapes β-tubulin, defining the complex as a regulated folding intermediate.","evidence":"HDX-MS, nucleotide-binding assays, and comparison of ARL2 monomer versus trimer dynamics","pmids":["28970104"],"confidence":"High","gaps":["Downstream fate of the conformationally altered β-tubulin not tracked","Timing of nucleotide cycling relative to heterodimer release unresolved"]},{"year":2017,"claim":"Documented TBCD and TBCE expression and localization in human gametes, raising a possible role in reproductive cells.","evidence":"RT-PCR, western blot, and immunofluorescence on human sperm and oocytes","pmids":["28583220"],"confidence":"Low","gaps":["No functional consequence tested in gametes","Single descriptive study without loss-of-function validation"]},{"year":2023,"claim":"Confirmed causality of a pathogenic TBCD allele by isogenic correction, directly linking restored TBCD levels to rescued spindle organization and reduced cell death.","evidence":"CRISPR/Cas9 isogenic correction in patient iPSCs with protein, spindle, and cell-death readouts","pmids":["37175696"],"confidence":"Medium","gaps":["Single mutation corrected; generality across alleles not tested","Single lab"]},{"year":2025,"claim":"Defined a mechanism by which excess TBCD competes with α-tubulin for β-tubulin, driving α-tubulin degradation, microtubule depolymerization, and cell death via NF-κB/TNF-α and ROS signaling.","evidence":"Binding competition and depolymerization assays, RNA-seq, ROS measurement, and tumor xenografts using bovine TBCD","pmids":["41232862"],"confidence":"Medium","gaps":["Demonstrated for bovine, not human, TBCD","In vivo relevance of the NF-κB/TNF-α axis to physiological TBCD function unclear"]},{"year":null,"claim":"The atomic structure of the TBCD·ARL2·β-tubulin trimer and the precise sequence of conformational and nucleotide events linking it to heterodimer release remain undefined.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of the functional trimer","Coupling between centrosomal localization and tubulin folding mechanistically unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,2,4]}],"localization":[{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[1]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,4]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,3]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,8]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6]}],"complexes":["TBCD·ARL2·β-tubulin trimer"],"partners":["ARL2","TBCC","TBCE","TUBB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BTW9","full_name":"Tubulin-specific chaperone D","aliases":["Beta-tubulin cofactor D","tfcD","SSD-1","Tubulin-folding cofactor D"],"length_aa":1192,"mass_kda":132.6,"function":"Tubulin-folding protein implicated in the first step of the tubulin folding pathway and required for tubulin complex assembly. Involved in the regulation of microtubule polymerization or depolymerization, it modulates microtubule dynamics by capturing GTP-bound beta-tubulin (TUBB). Its ability to interact with beta tubulin is regulated via its interaction with ARL2. Acts as a GTPase-activating protein (GAP) for ARL2. Induces microtubule disruption in absence of ARL2. Increases degradation of beta tubulin, when overexpressed in polarized cells. Promotes epithelial cell detachment, a process antagonized by ARL2. Induces tight adherens and tight junctions disassembly at the lateral cell membrane (PubMed:10722852, PubMed:10831612, PubMed:11847227, PubMed:20740604, PubMed:27666370, PubMed:28158450). Required for correct assembly and maintenance of the mitotic spindle, and proper progression of mitosis (PubMed:27666370). Involved in neuron morphogenesis (PubMed:27666374)","subcellular_location":"Cell junction, tight junction; Lateral cell membrane; Cytoplasm; Cell junction, adherens junction; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome","url":"https://www.uniprot.org/uniprotkb/Q9BTW9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/TBCD","classification":"Common Essential","n_dependent_lines":1170,"n_total_lines":1208,"dependency_fraction":0.9685430463576159},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ARL2","stoichiometry":10.0},{"gene":"TUBB4B","stoichiometry":4.0},{"gene":"CLINT1","stoichiometry":0.2},{"gene":"MAP4","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/TBCD","total_profiled":1310},"omim":[{"mim_id":"617193","title":"ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT","url":"https://www.omim.org/entry/617193"},{"mim_id":"610451","title":"TUBULIN FOLDING COFACTOR E-LIKE; TBCEL","url":"https://www.omim.org/entry/610451"},{"mim_id":"604934","title":"TUBULIN FOLDING COFACTOR E; TBCE","url":"https://www.omim.org/entry/604934"},{"mim_id":"604649","title":"TUBULIN FOLDING COFACTOR D; TBCD","url":"https://www.omim.org/entry/604649"},{"mim_id":"602082","title":"CORNEAL DYSTROPHY, THIEL-BEHNKE TYPE; CDTB","url":"https://www.omim.org/entry/602082"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/TBCD"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9BTW9","domains":[{"cath_id":"1.10.1240","chopping":"33-114","consensus_level":"medium","plddt":92.1579,"start":33,"end":114},{"cath_id":"1.25.10","chopping":"1015-1179","consensus_level":"medium","plddt":92.5824,"start":1015,"end":1179}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BTW9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BTW9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BTW9-F1-predicted_aligned_error_v6.png","plddt_mean":90.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TBCD","jax_strain_url":"https://www.jax.org/strain/search?query=TBCD"},"sequence":{"accession":"Q9BTW9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BTW9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BTW9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BTW9"}},"corpus_meta":[{"pmid":"27666370","id":"PMC_27666370","title":"Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27666370","citation_count":67,"is_preprint":false},{"pmid":"27666374","id":"PMC_27666374","title":"Biallelic TBCD Mutations Cause Early-Onset Neurodegenerative Encephalopathy.","date":"2016","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27666374","citation_count":54,"is_preprint":false},{"pmid":"20740604","id":"PMC_20740604","title":"Effect of TBCD and its regulatory interactor Arl2 on tubulin and microtubule integrity.","date":"2010","source":"Cytoskeleton (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/20740604","citation_count":41,"is_preprint":false},{"pmid":"28126905","id":"PMC_28126905","title":"A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and β-Tubulin Is Required for Maintaining the Microtubule Network.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28126905","citation_count":40,"is_preprint":false},{"pmid":"28158450","id":"PMC_28158450","title":"Infantile neurodegenerative disorder associated with mutations in TBCD, an essential gene in the tubulin heterodimer assembly pathway.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28158450","citation_count":30,"is_preprint":false},{"pmid":"20107510","id":"PMC_20107510","title":"TBCD links centriologenesis, spindle microtubule dynamics, and midbody abscission in human cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20107510","citation_count":27,"is_preprint":false},{"pmid":"27807845","id":"PMC_27807845","title":"Microcephaly, intractable seizures and developmental delay caused by biallelic variants in TBCD: further delineation of a new chaperone-mediated tubulinopathy.","date":"2016","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27807845","citation_count":25,"is_preprint":false},{"pmid":"28970104","id":"PMC_28970104","title":"Nucleotide Binding to ARL2 in the TBCD∙ARL2∙β-Tubulin Complex Drives Conformational Changes in β-Tubulin.","date":"2017","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28970104","citation_count":17,"is_preprint":false},{"pmid":"27928163","id":"PMC_27928163","title":"TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy.","date":"2016","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27928163","citation_count":15,"is_preprint":false},{"pmid":"31569255","id":"PMC_31569255","title":"Developmental Regression and Epilepsy of Infancy with Migrating Focal Seizures Caused by TBCD Mutation: A Case Report and Review of the Literature.","date":"2019","source":"Neuropediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/31569255","citation_count":9,"is_preprint":false},{"pmid":"31240573","id":"PMC_31240573","title":"Biallelic pathogenic variants in TBCD-related neurodevelopment disease with mild clinical features.","date":"2019","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/31240573","citation_count":8,"is_preprint":false},{"pmid":"29769041","id":"PMC_29769041","title":"Cortical atrophy and hypofibrinogenemia due to FGG and TBCD mutations in a single family: a case report.","date":"2018","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29769041","citation_count":7,"is_preprint":false},{"pmid":"34943336","id":"PMC_34943336","title":"Novel Compound Heterozygous Variants in TBCD Gene Associated with Infantile Neurodegenerative Encephalopathy.","date":"2021","source":"Children (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34943336","citation_count":5,"is_preprint":false},{"pmid":"36527993","id":"PMC_36527993","title":"PEBAT, an Intriguing Neurodegenerative Tubulinopathy Caused by a Novel Homozygous Variant in TBCD: A Case Series and Literature Review.","date":"2022","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/36527993","citation_count":3,"is_preprint":false},{"pmid":"37175696","id":"PMC_37175696","title":"CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37175696","citation_count":3,"is_preprint":false},{"pmid":"28583220","id":"PMC_28583220","title":"Expression and localization of tubulin cofactors TBCD and TBCE in human gametes.","date":"2017","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28583220","citation_count":1,"is_preprint":false},{"pmid":"37394437","id":"PMC_37394437","title":"[MOH SCREENING FOR TBCD IN COCHIN JEWS: COLLABORATION BETWEEN MEDICAL, RESEARCH AND COMMUNITY MEMBERS IN ACHIEVING PUBLIC HEALTH GOALS].","date":"2023","source":"Harefuah","url":"https://pubmed.ncbi.nlm.nih.gov/37394437","citation_count":1,"is_preprint":false},{"pmid":"41232862","id":"PMC_41232862","title":"Bovine tubulin cofactor D (TBCD) disrupts tubulin dimers and inhibits tumor growth via the TNF-α signaling pathways-mediated ROS production.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41232862","citation_count":0,"is_preprint":false},{"pmid":"37569761","id":"PMC_37569761","title":"A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37569761","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.05.20.655204","title":"Saliva-based Biomarkers for Predicting Gastric Cancer","date":"2025-05-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.20.655204","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.29.641201","title":"REpair of heterozygous Mutations independent of Exogenous Donor template with high efficiency (REMEDY) using allele specific CRISPR targeting and HDR enhancers","date":"2025-05-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.29.641201","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11641,"output_tokens":3203,"usd":0.041484,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10778,"output_tokens":3083,"usd":0.065482,"stage2_stop_reason":"end_turn"},"total_usd":0.106966,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"TBCD functions in vitro in CCT-driven tubulin folding reactions and in tubulin disruption reactions; it also acts as a GTPase-activating protein (GAP) together with TBCC to stimulate GTP hydrolysis by β-tubulin in the heterodimer at concentrations below those required for polymerization. Bovine TBCD forms a stoichiometric co-complex with β-tubulin when expressed in HeLa cells, whereas human TBCD does not. siRNA-mediated suppression of ARL2 enables human TBCD to disrupt microtubule integrity in vivo, demonstrating that ARL2 negatively regulates TBCD's microtubule-destabilizing activity.\",\n      \"method\": \"In vitro CCT folding assays, tubulin disruption assays, GTPase-activating protein (GAP) assays, recombinant protein expression in HeLa cells with Co-IP/co-complex analysis, siRNA knockdown of ARL2\",\n      \"journal\": \"Cytoskeleton (Hoboken, N.J.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal in vitro biochemical assays (folding, disruption, GAP activity) combined with cell-based genetic suppression (siRNA of ARL2), all in a single focused mechanistic study\",\n      \"pmids\": [\"20740604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"TBCD localizes to the centrosome and midbody in a cell-cycle-dependent manner: at the daughter centriole in G1, on procentrioles in S phase, and at the midbody during cytokinesis. Overexpression of TBCD causes microtubule release from the centrosome and G1 arrest; depletion causes mitotic aberrations and incomplete microtubule retraction at the midbody during cytokinesis. In differentiating ciliated cells, TBCD organizes into centriolar rosettes, supporting a role in both canonical and de novo centriolar assembly.\",\n      \"method\": \"Immunofluorescence localization, cell-cycle staging, TBCD overexpression and siRNA depletion with phenotypic readouts (mitotic aberrations, G1 arrest, cytokinesis defects), analysis in differentiating ciliated cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization experiments with defined functional consequences from both loss-of-function (depletion) and gain-of-function (overexpression), multiple orthogonal readouts in a single study\",\n      \"pmids\": [\"20107510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBCD, ARL2, and β-tubulin form a stable ~200 kDa trimeric complex (TBCD·ARL2·β-tubulin) in mouse tissues and multiple cell lines. The trimer was purified from human embryonic kidney cells. ARL2 point mutants that disrupt binding to TBCD impair proper maintenance of microtubule densities in cells, establishing that the ARL2–TBCD interaction within the trimer is required for normal microtubule network maintenance.\",\n      \"method\": \"Non-denaturing gel electrophoresis with immunoblotting, affinity purification from HEK cells, ARL2 point mutant analysis, microtubule density quantification\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — complex purified and characterized by multiple methods (native gels, immunoblot, purification), mutational validation of functional significance, replicated across tissues and cell lines\",\n      \"pmids\": [\"28126905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Within the TBCD·ARL2·β-tubulin trimer, it is ARL2 (not β-tubulin) that exchanges GTP; ARL2 nucleotide-binding affinity for GTP is increased within the trimer compared to ARL2 monomer. Guanine nucleotide binding to ARL2 drives conformational changes in β-tubulin as detected by altered solvent accessibility. β-tubulin in the trimer also co-purifies with guanine nucleotide. The complex represents a functional intermediate in the β-tubulin folding pathway regulated by ARL2 nucleotide cycling.\",\n      \"method\": \"Hydrogen/deuterium exchange mass spectrometry (HDX-MS), nucleotide-binding assays, comparison of ARL2 monomer vs. trimer dynamics\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural dynamics (HDX-MS) combined with direct nucleotide-binding assays and mutagenesis-informed modeling, single lab but multiple orthogonal biochemical methods\",\n      \"pmids\": [\"28970104\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pathogenic missense mutations in TBCD reduce protein stability (variably reduced TBCD levels in patient fibroblasts) and impair β-tubulin binding. Loss of TBCD function decreases soluble α/β-tubulin levels and accelerates microtubule polymerization, resulting in a more rapidly growing, stable microtubule population. Patient fibroblasts display aberrant mitotic spindles with disorganized tangle-shaped microtubules and reduced aster formation.\",\n      \"method\": \"Biochemical analysis of patient-derived fibroblasts (protein level quantification, β-tubulin binding assays), microtubule polymerization assays, immunofluorescence of mitotic spindles, molecular dynamics simulations\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (binding assays, polymerization assays, spindle imaging) in patient-derived cells, independently replicated across two simultaneous publications\",\n      \"pmids\": [\"27666370\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Most pathogenic TBCD missense mutations impair binding of TBCD to ARL2, TBCE, and β-tubulin in cell-based interaction experiments. In vivo experiments using Drosophila melanogaster olfactory projection neurons showed TBCD mutations cause loss-of-function phenotypes.\",\n      \"method\": \"In vitro cell-based binding experiments (co-immunoprecipitation/pulldown of mutant TBCD with ARL2, TBCE, β-tubulin), Drosophila in vivo genetics\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-based binding and in vivo model organism experiments with functional readout, single lab\",\n      \"pmids\": [\"27666374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In utero shRNA-mediated suppression of tbcd in the developing mouse brain impairs cortical cell proliferation and radial migration, establishing TBCD as required for normal cerebral cortex development. Mutant TBCD proteins (A475T and A586V) show partially compromised ability to participate in the heterodimer assembly pathway, with reduced intracellular TBCD abundance (~10% and ~40% of control, respectively).\",\n      \"method\": \"In utero shRNA knockdown in mouse brain with histological analysis of cell proliferation and radial migration; functional assembly assays with mutant proteins; protein quantification in patient fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic loss-of-function (in utero shRNA) with defined cellular phenotype plus biochemical functional assay of mutant proteins, multiple orthogonal methods\",\n      \"pmids\": [\"28158450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Reduced TBCD expression in patient fibroblasts is associated with accelerated microtubule re-polymerization. Morpholino-mediated TBCD knockdown in zebrafish recapitulates key disease pathological features, and TBCD overexpression in zebrafish confirms an obligate dependency on proper TBCD dosage for normal development.\",\n      \"method\": \"Microtubule re-polymerization assays in patient-derived fibroblasts, morpholino knockdown and overexpression in zebrafish with phenotypic analysis\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two model systems (patient fibroblasts and zebrafish) with functional readouts, single lab\",\n      \"pmids\": [\"27807845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRISPR/Cas9 correction of a pathogenic TBCD missense substitution in patient-derived iPSCs restored proper TBCD protein levels, rescued mitotic spindle organization, and reduced cellular death, confirming that loss of TBCD function directly causes mitotic spindle disorganization and increased cell death.\",\n      \"method\": \"CRISPR/Cas9 isogenic iPSC correction, protein level quantification, mitotic spindle immunofluorescence, cell death assays\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic correction with multiple functional readouts (protein level, spindle organization, cell death), single lab\",\n      \"pmids\": [\"37175696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Bovine TBCD (bTBCD) specifically competes with α-tubulin to bind β-tubulin; when bTBCD binds β-tubulin, it fails to form a functional TBCD/β-tubulin/ARL2 complex, resulting in α-tubulin degradation and microtubule depolymerization. This depolymerization combined with an unbalanced β/α-tubulin ratio leads to cell cycle arrest and cell death via activation of non-canonical NF-κB and TNF-α signaling pathways with increased ROS production.\",\n      \"method\": \"Protein binding competition assays, microtubule depolymerization assays, RNA-seq pathway analysis, ROS measurement, in vivo tumor xenograft experiments\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple biochemical and cell-based assays in a single lab study; bovine TBCD specifically, not human TBCD\",\n      \"pmids\": [\"41232862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TBCD and TBCE proteins are expressed in human sperm (localized mainly to the middle piece and tail) and in human oocytes (cytosolic localization), as determined by RT-PCR, western blot, and immunofluorescence. TBCD mRNA is present in oocytes but not sperm.\",\n      \"method\": \"RT-PCR, western blot, immunofluorescence on human sperm and oocytes\",\n      \"journal\": \"Zygote (Cambridge, England)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — localization established by immunofluorescence in gametes with no functional consequence tested; single lab, single study\",\n      \"pmids\": [\"28583220\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TBCD is a tubulin-specific chaperone that functions downstream of the CCT chaperonin to facilitate de novo αβ-tubulin heterodimer assembly; it forms a stable ~200 kDa trimer with ARL2 and β-tubulin (the functional form in cells), acts together with TBCC as a GTPase-activating protein for β-tubulin, and can also drive heterodimer disassembly—an activity negatively regulated by ARL2—while at the centrosome/midbody it participates in centriologenesis, spindle organization, and cytokinetic abscission, with nucleotide cycling on ARL2 within the trimer driving conformational changes in β-tubulin to regulate the β-tubulin folding pathway.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TBCD is a tubulin-specific cofactor that operates downstream of the CCT chaperonin in the de novo assembly of αβ-tubulin heterodimers, where it functions in CCT-driven folding reactions and, together with TBCC, acts as a GTPase-activating protein stimulating GTP hydrolysis by β-tubulin within the heterodimer [#0]. In cells its functional form is a stable ~200 kDa trimer of TBCD, ARL2, and β-tubulin, and disruption of the ARL2–TBCD interaction impairs maintenance of normal microtubule densities [#2]; within this trimer it is ARL2, not β-tubulin, that exchanges guanine nucleotide, and ARL2 nucleotide cycling drives conformational changes in β-tubulin, making the complex a regulated intermediate in the β-tubulin folding pathway [#3]. TBCD additionally drives tubulin heterodimer disassembly, an activity that ARL2 negatively regulates, since suppression of ARL2 allows TBCD to disrupt microtubule integrity in vivo [#0]. TBCD localizes to the centrosome and midbody in a cell-cycle-dependent manner and contributes to centriologenesis, spindle organization, and cytokinesis, with overexpression causing microtubule release and G1 arrest and depletion causing mitotic and cytokinetic defects [#1]. Pathogenic missense mutations in TBCD reduce protein stability and impair binding to β-tubulin, ARL2, and TBCE, lowering soluble tubulin levels, accelerating microtubule polymerization, and producing disorganized mitotic spindles [#4, #5]; loss of TBCD function impairs cortical neuron proliferation and radial migration and causes a neurodevelopmental disorder, with CRISPR correction of a patient mutation rescuing spindle organization and cell death [#6, #8].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Established the dual biochemical activities of TBCD in the tubulin pathway, showing it both participates in folding and acts as a β-tubulin GAP with TBCC, while identifying ARL2 as a negative regulator of its destabilizing activity.\",\n      \"evidence\": \"In vitro CCT folding, tubulin disruption, and GAP assays plus recombinant expression and ARL2 siRNA in HeLa cells\",\n      \"pmids\": [\"20740604\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of ARL2 regulation\", \"Difference between bovine and human TBCD co-complex behavior unexplained\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defined TBCD's spatial and cell-cycle-dependent role at centrosomes and midbody, linking its biochemical activity to centriologenesis, spindle organization, and cytokinesis.\",\n      \"evidence\": \"Immunofluorescence localization with overexpression and siRNA phenotyping in cultured and differentiating ciliated cells\",\n      \"pmids\": [\"20107510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism connecting tubulin chaperone activity to centriole assembly not defined\", \"Direct centriolar binding partners not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected TBCD to human disease by showing pathogenic mutations destabilize the protein, impair tubulin/cofactor binding, perturb microtubule dynamics, and cause neurodevelopmental phenotypes in patient cells and model organisms.\",\n      \"evidence\": \"Patient fibroblast biochemistry, microtubule polymerization assays, spindle imaging, in utero mouse shRNA, zebrafish morpholino, and Drosophila genetics\",\n      \"pmids\": [\"27666370\", \"27666374\", \"28158450\", \"27807845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlation across mutations incompletely resolved\", \"Brain-specific dependency mechanism not fully defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved the functional form of TBCD in cells as a stable trimer with ARL2 and β-tubulin and showed the ARL2-TBCD interface is required for microtubule network maintenance.\",\n      \"evidence\": \"Native gels, affinity purification from HEK cells, and ARL2 point mutant analysis with microtubule density quantification across tissues and cell lines\",\n      \"pmids\": [\"28126905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the trimer not determined\", \"Stoichiometry of higher-order assemblies unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established the nucleotide logic of the trimer, demonstrating that ARL2 (not β-tubulin) cycles GTP and that ARL2 nucleotide binding allosterically reshapes β-tubulin, defining the complex as a regulated folding intermediate.\",\n      \"evidence\": \"HDX-MS, nucleotide-binding assays, and comparison of ARL2 monomer versus trimer dynamics\",\n      \"pmids\": [\"28970104\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream fate of the conformationally altered β-tubulin not tracked\", \"Timing of nucleotide cycling relative to heterodimer release unresolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Documented TBCD and TBCE expression and localization in human gametes, raising a possible role in reproductive cells.\",\n      \"evidence\": \"RT-PCR, western blot, and immunofluorescence on human sperm and oocytes\",\n      \"pmids\": [\"28583220\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional consequence tested in gametes\", \"Single descriptive study without loss-of-function validation\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Confirmed causality of a pathogenic TBCD allele by isogenic correction, directly linking restored TBCD levels to rescued spindle organization and reduced cell death.\",\n      \"evidence\": \"CRISPR/Cas9 isogenic correction in patient iPSCs with protein, spindle, and cell-death readouts\",\n      \"pmids\": [\"37175696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single mutation corrected; generality across alleles not tested\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a mechanism by which excess TBCD competes with α-tubulin for β-tubulin, driving α-tubulin degradation, microtubule depolymerization, and cell death via NF-κB/TNF-α and ROS signaling.\",\n      \"evidence\": \"Binding competition and depolymerization assays, RNA-seq, ROS measurement, and tumor xenografts using bovine TBCD\",\n      \"pmids\": [\"41232862\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Demonstrated for bovine, not human, TBCD\", \"In vivo relevance of the NF-κB/TNF-α axis to physiological TBCD function unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The atomic structure of the TBCD·ARL2·β-tubulin trimer and the precise sequence of conformational and nucleotide events linking it to heterodimer release remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of the functional trimer\", \"Coupling between centrosomal localization and tubulin folding mechanistically unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 8]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\"TBCD·ARL2·β-tubulin trimer\"],\n    \"partners\": [\"ARL2\", \"TBCC\", \"TBCE\", \"TUBB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}